Metformin treatment was associated with inhibition of mTOR/p6S6K/pS1 signaling and downregulation of pERK in MTC-derived TT and MZ-CRC-70 cell lines [75]. The gene discussed is EIF2AK3; the disease is colorectal carcinoma.